Drugs not distinguished in NICE schizophrenia guideline
This article was originally published in Scrip
Executive Summary
The UK's National Institute for health and Clinical Excellence (NICE) says that patients with newly diagnosed schizophrenia should be offered oral antipsychotic medication. But the institute makes no distinction between the different therapies available, recommending only that patients and prescribers discuss the benefits and side-effect profile of each drug.